Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Biotek-snakken
  4. Biotek-snakken — Maj 2023

Biotek-snakken — Maj 2023

Planlagt Fastgjort Låst Flyttet Biotek-snakken
129 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • exitnuE Offline
    exitnuE Offline
    exitnu
    wrote on sidst redigeret af
    #115

    God weekend!

    1 Reply Last reply
    0
    • F Offline
      F Offline
      Fandel
      wrote on sidst redigeret af
      #116

      Godmorgen...

      1 Reply Last reply
      0
      • exitnuE Offline
        exitnuE Offline
        exitnu
        wrote on sidst redigeret af
        #117

        God morgen 🙂

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #118

          HC Wainwright & Co. Reiterates Gracell Biotechnologies Inc - ADR (GRCL) Buy Recommendation
          https://www.proinvestor.com/investornyt/992557/hc-wainwright-amp-co-reiterates-gracell-biotechnologies-inc-adr-grcl-buy-recommendation

          1 Reply Last reply
          0
          • exitnuE Offline
            exitnuE Offline
            exitnu
            wrote on sidst redigeret af
            #119

            UPDATE: FDA needs more time for Sarepta's DMD gene therapy—spurring a deja vu of Exondys 51

            (May 24, 2023 08:39am)

            Just a moment...

            favicon

            (www.fiercebiotech.com)

            "The FDA needs a wee bit more time to consider the approval of Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy (DMD), however, the agency has indicated an accelerated approval is likely in a restricted age group."

            1 Reply Last reply
            0
            • exitnuE Offline
              exitnuE Offline
              exitnu
              wrote on sidst redigeret af
              #120

              EMBARK toplinje-resultater forventes i fjerde kvartal.

              1 Reply Last reply
              0
              • exitnuE Offline
                exitnuE Offline
                exitnu
                wrote on sidst redigeret af
                #121

                RBC Capital Markets har sat et nyt Sarepta Therapeutics kursmål på USD 218 med anbefalingen Outperform ... RBC ser en smule negativt på meldingen fra FDA men anbefaler dog at købe på et tilbagefald.

                https://pbs.twimg.com/media/FxA6F9NWIAI6SCZ?format=png&name=900x900

                1 Reply Last reply
                0
                • F Offline
                  F Offline
                  Fandel
                  wrote on sidst redigeret af
                  #122

                  Godmorgen...

                  1 Reply Last reply
                  0
                  • F Offline
                    F Offline
                    Fandel
                    wrote on sidst redigeret af
                    #123

                    Godmorgen...

                    1 Reply Last reply
                    0
                    • L Offline
                      L Offline
                      LP90
                      wrote on sidst redigeret af
                      #124

                      Godmorgen 🙂

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #125

                        BIOTEC: Euforien i 2020 ga kunstig høy verdsettelse, men nå har verdier for 24,2 milliarder kroner forduftet blant biotek-aksjene på Oslo Børs de seneste to årene. – Hele bioteknologisektoren globalt har fått seg en smell. Det er syklisk, og jeg har etter 23 år i bransjen vært med på noen opp- og nedturer, sier Jónas Einarsson i Radforsk. (Fa+)

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          ProinvestorNEWS
                          wrote on sidst redigeret af
                          #126

                          Bioporto vil rejse tocifret millionbeløb via salg af nye aktier til 1 kr. per styk
                          https://www.proinvestor.com/investornyt/993487/bioporto-vil-rejse-tocifret-millionbelob-via-salg-af-nye-aktier-til-1-kr-per-styk

                          1 Reply Last reply
                          0
                          • F Offline
                            F Offline
                            Fandel
                            wrote on sidst redigeret af
                            #127

                            Godmorgen...

                            1 Reply Last reply
                            0
                            • L Offline
                              L Offline
                              LP90
                              wrote on sidst redigeret af
                              #128

                              Godmorgen 🙂

                              1 Reply Last reply
                              0
                              • V Offline
                                V Offline
                                VærKritisk
                                wrote on sidst redigeret af
                                #129

                                Bioportos emissioner minder om en kvindes cyklus. Emissioner og menstruationer falder med stor regelsmæssighed

                                1 Reply Last reply
                                0
                                • U Offline
                                  U Offline
                                  Urban
                                  wrote on sidst redigeret af
                                  #130

                                  Xbrane (Stockholm) Xbranes vd Martin Åmark uppgav i vd-ordet att han bedömer att bolaget kommer att det kommer att bli kassaflödespositivt under 2023 i enlighet med bolagets mål.

                                  1 Reply Last reply
                                  0

                                  Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                  Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                  With your input, this post could be even better 💗

                                  Tilmeld Log ind
                                  Svar
                                  • Svar som emne
                                  Login for at svare
                                  • Ældste til nyeste
                                  • Nyeste til ældste
                                  • Most Votes


                                  • Log ind

                                  • Har du ikke en konto? Tilmeld

                                  • Login or register to search.
                                  Powered by NodeBB Contributors
                                  • First post
                                    Last post
                                  0
                                  • Kategorier
                                  • Seneste
                                  • Etiketter
                                  • Populære
                                  • Verden
                                  • Bruger
                                  • Grupper